Yahoo Web Search

  1. Allergan (AGN) Shareholders Approve Acquisition by AbbVie

    Zacks via Yahoo FinanceOct 15 21:04 PM

    Allergan plc AGN announced that its shareholders have approved its pending acquisition by AbbVie, Inc. ABBV. Allergan said that approximately 68.6% of shareholders eligible ...

  2. Here Is Hedge Funds’ 22nd Most Popular Stock Pick

    Insider Monkey via Yahoo FinanceOct 03 21:30 PM

    Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. A particularly interesting group of stocks ...

  3. Biotech stocks that hit 52-week lows Oct. 8. ABIOMED, Inc. NASDAQ: ABMD) Adamas Pharmaceuticals Inc (NASDAQ: ADMS) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP) AEterna Zentaris Inc.

  4. DuPont de Nemours, Inc. NYSE:DD) has experienced a decrease in hedge fund sentiment of late. Overall hedge fund sentiment towards the stock is at its all time low.

  5. Hedge Funds Have Never Been Less Bullish On General Motors Company (GM)

    Insider Monkey via Yahoo FinanceOct 09 23:31 PM

    How do we determine whether General Motors Company (NYSE:GM) makes for a good investment at the moment? General Motors Company (NYSE:GM) was in 49 hedge funds' portfolios at the end of June.

  6. Hedge Funds Are Undecided About Ecolab Inc. (ECL)

    Insider Monkey via Yahoo FinanceOct 09 16:22 PM

    How do we determine whether Ecolab Inc. (NYSE:ECL) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense ...

  7. Is The Blackstone Group Inc. (BX) Going to Burn These Hedge Funds?

    Insider Monkey via Yahoo FinanceOct 09 14:41 PM

    The last 12 months is one of those periods, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by more than 10 percentage points. In this article, we use our extensive ...

  8. J&J Settles Ahead of Multi-District Opioid Trial, Stock Up

    Zacks via Yahoo FinanceOct 03 15:16 PM

    Shares of Johnson & Johnson JNJ gained 1.6% after it announced a settlement agreement with Cuyahoga and Summit counties related to the multidistrict opioid litigation (“MDL”) in the U.S. District ...

  9. The recent FDA approval of Novartis AG’s NVS Beovu (brolucizumab) injection for the treatment of wet age-related macular degeneration (AMD) has put the spotlight on this promising space. What ...

  10. Johnson & Johnson JNJ is set to report their third quarter results as pending lawsuits loom over the company. The pharmaceutical giant’s shares have barely moved in 2019 thus far, rising only ...